What is the official website of Biopharma Dealmakers ?

The official website of Biopharma Dealmakers is https://www.nature.com/biopharmdeal.

What is Biopharma Dealmakers's cybersecurity risk score?

Biopharma Dealmakers has an AI-generated cybersecurity risk score of 752 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Biopharma Dealmakers experienced?

According to Rankiteo, Biopharma Dealmakers currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Biopharma Dealmakers been affected by any supply chain cyber incidents ?

According to Rankiteo, Biopharma Dealmakers has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Biopharma Dealmakers have SOC 2 Type 1 certification ?

According to Rankiteo, Biopharma Dealmakers is not certified under SOC 2 Type 1.

Does Biopharma Dealmakers have SOC 2 Type 2 certification ?

According to Rankiteo, Biopharma Dealmakers does not hold a SOC 2 Type 2 certification.

Does Biopharma Dealmakers comply with GDPR ?

According to Rankiteo, Biopharma Dealmakers is not listed as GDPR compliant.

Does Biopharma Dealmakers have PCI DSS certification ?

According to Rankiteo, Biopharma Dealmakers does not currently maintain PCI DSS compliance.

Does Biopharma Dealmakers comply with HIPAA ?

According to Rankiteo, Biopharma Dealmakers is not compliant with HIPAA regulations.

Does Biopharma Dealmakers have ISO 27001 certification ?

According to Rankiteo,Biopharma Dealmakers is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Biopharma Dealmakers operate in ?

Biopharma Dealmakers operates primarily in the Biotechnology Research industry.

How many employees does Biopharma Dealmakers have ?

Biopharma Dealmakers employs approximately None employees people worldwide.

Does Biopharma Dealmakers own any subsidiaries ?

Biopharma Dealmakers presently has no subsidiaries across any sectors.

How many LinkedIn followers does Biopharma Dealmakers have ?

Biopharma Dealmakers's official LinkedIn profile has approximately 3,004 followers.

What is the NAICS classification code for Biopharma Dealmakers ?

Biopharma Dealmakers is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Biopharma Dealmakers have a Crunchbase profile ?

No, Biopharma Dealmakers does not have a profile on Crunchbase.

Does Biopharma Dealmakers have a LinkedIn profile ?

Yes, Biopharma Dealmakers maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/biopharmadealmakers.

How many cybersecurity incidents has Biopharma Dealmakers experienced ?

As of June 4, 2026, Rankiteo reports that Biopharma Dealmakers has not experienced any cybersecurity incidents.

How many peer or competitor companies does Biopharma Dealmakers have ?

Biopharma Dealmakers has an estimated 4,694 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Biopharma Dealmakers

Boost Score +25 with badge (5 left)

752

/1000

Fair

777

/1000

Fair

Biopharma Dealmakers Vendor Cyber Rating & Cyber Score

nature.com

Add Your Compliance Badge

Biopharma Dealmakers – a Nature Research publication – showcases active partnering companies and their opportunities across the biopharma industry.

Biopharma Dealmakers A.I CyberSecurity Scoring

Scoring History

Biopharma Dealmakers

Biopharma Dealmakers CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Biopharma Dealmakers Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Biopharma Dealmakers

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Biopharma Dealmakers in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Biopharma Dealmakers in 2026.

Incident Types Biopharma Dealmakers vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Biopharma Dealmakers in 2026.

Incident History - Biopharma Dealmakers (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Biopharma Dealmakers Subsidiaries

Biopharma Dealmakers

Biotechnology Research

Website: https://www.nature.com/biopharmdeal

Company Size: 11-50 employees

Nature PortfolioBook and Periodical Publishing

Springer NatureBook and Periodical Publishing

Springer Nature in IndiaBook and Periodical Publishing

Macmillan EducationEducation Administration Programs

Scientific AmericanBook and Periodical Publishing

Palgrave MacmillanBook and Periodical Publishing

BMCBook and Periodical Publishing

Springer HealthcareEducation

Springer Healthcare Independent Medical Education (IME)Education Administration Programs

inScience CommunicationsPharmaceutical Manufacturing

Springer Healthcare IndiaPharmaceutical Manufacturing

Springer MedicineEducation

Springer Healthcare TrainingPharmaceutical Manufacturing

Medicine MattersHospitals and Health Care

Medicine Matters insightsHospitals and Health Care

Spektrum der Wissenschaft Verlagsgesellschaft mbHMedia Production

Research SquareBook and Periodical Publishing

ApressInternet Publishing

BSL Media & LearningBook and Periodical Publishing

Secretaresses in de ZorgZiekenhuizen en gezondheidszorg

Springer Healthcare ItaliaBook and Periodical Publishing

Prix Galien ItaliaBook and Periodical Publishing

SpringerBook and Periodical Publishing

Springer MedizinBook and Periodical Publishing

Springer MediaBook and Periodical Publishing

Cureus JournalsBook and Periodical Publishing

The Link, Springer NatureBook and Periodical Publishing

Springer Custom MediaAdvertising Services

Nature MagazinePeriodical Publishing

Nature MasterclassesResearch Services

Nature Custom MediaAdvertising Services

Loading…

Biopharma Dealmakers Similar Companies

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Gilead Sciences

cb gilead.com

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

Fortrea

fortrea.com

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

Charles River Laboratories

criver.com

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Loading…

NEWS

Biopharma Dealmakers CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

December 12, 2025 11:46 AM

Biopharma’s 2025 M&A boom: Dealmaking surges as patent pressures intensify

Propelled by a flurry of dealmaking late in the year, 2025 M&A ended on a strong note, with high activity expected to continue in 2026.

Read Article

January 08, 2024 08:00 AM

Life sciences dealmaking in a time of change

Life sciences companies are returning to dealmaking amid cost and revenue pressures – how will they find the right deals to secure value?

Read Article

December 07, 2016 01:25 PM

Neal, Gerber & Eisenberg LLP - United States Firm

Neal Gerber Eisenberg is one of the largest single-office law firms in the nation. The scope of our practice is both international and domestic.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-10777

SUMMARY

A vulnerability was identified in ealpha072 Student-Management-System up to 01451bd7a2f58cdda07bd0b86e3967582e3ecd08. Affected by this issue is some unknown functionality of the file admin/config.php of the component Administrative Backend. Such manipulation leads to improper authentication. The attack may be performed from remote. The exploit is publicly available and might be used. This product utilizes a rolling release system for continuous delivery, and as such, version information for affected or updated releases is not disclosed. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-06-03

Updated

Date2026-06-03

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-10775

SUMMARY

A vulnerability was determined in sgl-project SGLang up to 0.5.11. Affected by this vulnerability is the function data_hash of the component Cache Handler. This manipulation causes denial of service. The attack is restricted to local execution. A high degree of complexity is needed for the attack. The exploitation appears to be difficult. The exploit has been publicly disclosed and may be utilized. The pull request to fix this issue awaits acceptance.

Published

Date2026-06-03

Updated

Date2026-06-03

RISK INFORMATION (Score: 3.6)

cvss2

Base Score: 2.4

Complexity: HIGH

AV:L/AC:H/Au:S/C:N/I:P/A:P

cvss3

Base Score: 3.6

Complexity: HIGH

CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:U/C:N/I:L/A:L

cvss4

Base Score: 1.1

Complexity: HIGH

CVSS:4.0/AV:L/AC:H/AT:N/PR:L/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

REFERENCES

CVE-2026-22055

SUMMARY

Active IQ OneCollect version 2.7.3 contains hard-coded credentials that could allow an authenticated attacker with low privileges to perform unauthorized AutoSupport operations.

Published

Date2026-06-03

Updated

Date2026-06-03

RISK INFORMATION (Score: )

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:N/SC:L/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://security.netapp.com/advisory/ntap-20260603-0002

CVE-2026-22054

SUMMARY

Active IQ Config Advisor version 6.7.3 contains hard-coded credentials that could allow an authenticated attacker with low privileges to perform unauthorized AutoSupport operations.

Published

Date2026-06-03

Updated

Date2026-06-03

RISK INFORMATION (Score: )

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:N/SC:L/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://security.netapp.com/advisory/ntap-20260603-0001

CVE-2026-10771

SUMMARY

A vulnerability was found in crmeb crmeb_java 1.4. Affected is the function RestTemplate.getForEntity of the file crmeb-common/src/main/java/com/zbkj/common/utils/RestTemplateUtil.java of the component base64 Qrcode Endpoint. The manipulation of the argument url results in server-side request forgery. The attack can be executed remotely. The exploit has been made public and could be used. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-06-03

Updated

Date2026-06-03

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…